aafuady.com

Call for more investment in cost-effective tuberculosis care

The global community is facing a considerable challenge to eliminate tuberculosis (TB). Although the global TB incidence rate has been falling in the latest decade, without substantial improvement to detect and treat TB, the decline rate is not fast enough to reach the 2025 milestone of a 50% TB incidence and 75% TB mortality reduction compared with those figures in 2015. Among big problems are many people with TB disease experience substantial delays in accessing and receiving appropriate care or are undiagnosed. It is a worrying situation that, besides onward transmission in the community, leads to unnecessary disability, life loss, and—at a monetary perspective—loss of economic growth.

 

See full article here: https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(21)00066-3/fulltext

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Good Knowledge but Poor Practice Toward COVID-19 Among Indonesian Youth
18 Juni 2021
COVID-19 cases have been increasing among young people as they are often considered to have low compliance...
Targeted vaccine allocation could increase the covid-19 vaccine benefits amidst its lack of availability: A mathematical modeling study in indonesia
18 Juni 2021
With a limited number of vaccines and healthcare capacity shortages, particularly in low-and middle-income...
COVID-19 and tuberculosis-related catastrophic costs
28 Maret 2021
The COVID-19 pandemic has created an unprecedented health crisis and a substantial socioeconomic impact....
Cost of seeking care for tuberculosis since the implementation of universal health coverage in Indonesia
28 Maret 2021
Background Although tuberculosis (TB) patients often incur high costs to access TB-related services,...
Catastrophic costs due to tuberculosis worsen treatment outcomes: a prospective cohort study in Indonesia
28 Maret 2021
Background While the incidence of catastrophic costs due to tuberculosis (TB) remains high, there...
Prognostic factors for TB-associated uveitis in the Asia-Pacific Region: results of a modified Delphi survey
28 Maret 2021
Background Prognostic factors for TB-associated uveitis (TBU) remain mostly unknown, due to the challenges...
Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios
28 Maret 2021
Background The World Health Organization’s End Tuberculosis Strategy states that no tuberculosis (TB)-affected...
A health economic evaluation of using N-terminal pro brain natriuretic peptide for the management of acute heart failure: A pilot study in an Indonesian tertiary referral hospital
28 Maret 2021
Heart failure represents a major health problem and economic burden also in development countries such...
Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia’s implementation of universal health coverage
28 Maret 2021
Background As well as imposing an economic burden on affected households, the high costs related to...
Adaptation of the Tool to Estimate Patient Costs Questionnaire into Indonesian Context for Tuberculosis-affected Households
28 Maret 2021
BACKGROUND:Indonesia is the second-highest country for tuberculosis (TB) incidence worldwide. Hence,...